WKN: | A0HG69 |
ISIN: | GB00B0LCW083 |
Land: | Großbritannien |
Branche: | Chemie, Pharma, Bio- & Medizintechnik |
Sektor: | Pharma |
Weshalb die Hikma Pharmaceuticals-Aktie
ein C-Rating hat,
erfahren Sie im Performance-Check
vom 30. August 2025 Info.
Rang | Datum | Vorjahr | Schluss | Performance |
---|---|---|---|---|
1 | 2014 | 14,27 | 24,71 | 73,16% |
2 | 2010 | 5,51 | 9,21 | 67,15% |
3 | 2009 | 3,45 | 5,51 | 59,71% |
4 | 2013 | 9,08 | 14,27 | 57,16% |
5 | 2018 | 12,65 | 18,16 | 43,56% |
6 | 2019 | 18,16 | 23,42 | 28,96% |
7 | 2015 | 24,71 | 31,50 | 27,48% |
8 | 2012 | 7,37 | 9,08 | 23,20% |
9 | 2020 | 23,42 | 28,10 | 19,98% |
10 | 2007 | 5,26 | 6,23 | 18,44% |
11 | 2023 | 17,40 | 20,40 | 17,24% |
12 | 2024 | 20,40 | 23,80 | 16,67% |
13 | 2021 | 28,10 | 26,60 | -5,34% |
14 | 2025 | 23,80 | 20,60 | -13,45% |
15 | 2011 | 9,21 | 7,37 | -19,98% |
16 | 2016 | 31,50 | 21,59 | -31,46% |
17 | 2022 | 26,60 | 17,40 | -34,59% |
18 | 2017 | 21,59 | 12,65 | -41,41% |
19 | 2008 | 6,23 | 3,45 | -44,62% |
Rang | Datum | Vorjahr | Schluss | Performance |
---|---|---|---|---|
1 | 2008 | 6,23 | 3,45 | -44,62% |
2 | 2017 | 21,59 | 12,65 | -41,41% |
3 | 2022 | 26,60 | 17,40 | -34,59% |
4 | 2016 | 31,50 | 21,59 | -31,46% |
5 | 2011 | 9,21 | 7,37 | -19,98% |
6 | 2025 | 23,80 | 20,60 | -13,45% |
7 | 2021 | 28,10 | 26,60 | -5,34% |
8 | 2024 | 20,40 | 23,80 | 16,67% |
9 | 2023 | 17,40 | 20,40 | 17,24% |
10 | 2007 | 5,26 | 6,23 | 18,44% |
11 | 2020 | 23,42 | 28,10 | 19,98% |
12 | 2012 | 7,37 | 9,08 | 23,20% |
13 | 2015 | 24,71 | 31,50 | 27,48% |
14 | 2019 | 18,16 | 23,42 | 28,96% |
15 | 2018 | 12,65 | 18,16 | 43,56% |
16 | 2013 | 9,08 | 14,27 | 57,16% |
17 | 2009 | 3,45 | 5,51 | 59,71% |
18 | 2010 | 5,51 | 9,21 | 67,15% |
19 | 2014 | 14,27 | 24,71 | 73,16% |